Andrew Stewart Plump
CIK: 0001977689
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TAKEDA PHARMACEUTICAL CO LTD
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Sep 2, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
Sale(S)Indirect116.2K shares at avg. $18.49$2.1M - Aug 19, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
Sale(S)Indirect19.7K shares at avg. $18.49$363K - Aug 10, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
Sale(S)Direct165.4K shares at avg. $17.10$2.8M - Jul 1, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
Award(A)Direct125.4K shares- - Apr 27, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
Award(A)Direct212.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 2, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | Sale(S) | 116,191 | $18.49 | $2,148,372 | Indirect |
| Aug 19, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | Sale(S) | 19,651 | $18.49 | $363,347 | Indirect |
| Aug 10, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | Sale(S) | 165,393 | $17.10 | $2,828,220 | Direct |
| Jul 1, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | Award(A) | 125,390 | - | $0 | Direct |
| Apr 27, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | Award(A) | 212,470 | - | $0 | Direct |
1-5 of 5 transactions
About Plump Andrew Stewart
Plump Andrew Stewart (SEC CIK 0001977689) files insider reports with the SEC as President, R&D of TAKEDA PHARMACEUTICAL CO LTD (TAK).
Signal8 holds 6 ownership filings by Plump Andrew Stewart (1 Form 3, 5 Form 4), filed between Mar 18, 2026 and Sep 3, 2026. Those filings report 5 transactions, from Apr 27, 2026 to Sep 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Plump Andrew Stewart's filings is in CAMBRIDGE, MA.
Recent filings by Plump Andrew Stewart
- Sep 2, 2026: Open-market sale of TAK shares (Form 4, code S).
- Aug 19, 2026: Open-market sale of TAK shares (Form 4, code S).
- Aug 10, 2026: Open-market sale of TAK shares (Form 4, code S).
- Jul 1, 2026: Grant or award of TAK shares (Form 4, code A).
- Apr 27, 2026: Grant or award of TAK shares (Form 4, code A).
Other insiders filing for TAKEDA PHARMACEUTICAL CO LTD (TAK)
- Duprey Lauren Rusckowski, Chief Transformation Officer
- Greenway Nicola Deidre Petal, Chief Human Resources Officer
- Farajallah Awny Samaan Botros, Chief Medical Officer
- Ibrahim Ramy Riad Ahmed, President, PDT BU
- Pacheco Rhonda Janice, President, U.S. Business Unit
- Pignagnoli Agosti Marcello, Head, Strat. & Port. Dev